Results 211 to 220 of about 260,746 (260)
Some of the next articles are maybe not open access.
Nature Reviews Cardiology, 2019
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire +3 more sources
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire +3 more sources
Beyond lowering LDL cholesterol
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2011Compelling evidence from randomized controlled studies demonstrated the crucial role of lowering low-density lipoprotein cholesterol (LDL-C) in the prevention of vascular events. However, not all patients with low LDL-C levels show similar reduction in event rates.
Ozgür, Bayturan +2 more
openaire +2 more sources
LDL cholesterol and atherosclerosis: The evidence.
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2021The lipid theory of atherosclerosis dates back more than a century. Despite this, some authors have questioned the relevance of hypercholesterolaemia in its development. Multiple experimental, epidemiological, and clinical evidence underpins this association.
Guijarro C, Cosin-Sales J
openaire +2 more sources
LDL Cholesterol: The Lower the Better
Medical Clinics of North America, 2012High cholesterol is often a prerequisite for atherosclerotic plaque. Low-density lipoprotein cholesterol (LDL-C) is the focus of the National Cholesterol Education Program Adult Treatment Panel guidelines. LDL-C ranges from 50 to 70 mg/dL in native hunter-gatherers, healthy human neonates, free-living primates, and other wild mammals, who are notably ...
Seth S, Martin +2 more
openaire +2 more sources
[LDL-Cholesterol--Is there an "LDL hypothesis"?].
Deutsche medizinische Wochenschrift (1946), 2015The term "LDL-Hypothesis" is frequently used to describe the association between LDL cholesterol (LDL-C) and cardiovascular outcomes. In the light of recent results of randomized trials the question arises whether the term hypothesis is still adequate.
Florian, Custodis, Ulrich, Laufs
openaire +1 more source
LDL cholesterol impairs therapy
Science Signaling, 2017A diet high in LDL cholesterol may hinder the therapeutic efficacy of tyrosine kinase inhibitors in cancer patients.
openaire +2 more sources
LDL cholesterol hitches a ride
Science Translational Medicine, 2016A new lipid-binding protein transports low-density lipoprotein across the blood vessel endothelium and might promote atherosclerosis.
openaire +2 more sources
Beyond LDL Cholesterol Reduction
Circulation, 1996Within the past decade, clinical trials of LDL-C reduction have convincingly demonstrated that LDL-C reduction in primary and secondary prevention trials can significantly reduce clinical cardiac events.1 Arteriographic investigations have demonstrated that LDL-C reduction can significantly reduce the rate of arteriographically defined disease ...
openaire +2 more sources

